Product image of Metoprololsuccinat Heumann (Metoprolol Succinate (Ph. Eur.)) supplied by GNH India

Metoprololsuccinat Heumann

Active Ingredient:
Metoprolol Succinate (Ph. Eur.)
Origin:
EU

Metoprololsuccinat Heumann (Metoprolol Succinate (Ph. Eur.))

Metoprolol succinate, the active ingredient in Metoprololsuccinat Heumann, is a beta blocker presented as an oral dosage form for oral use. It treats hypertension, chronic stable angina, heart failure with reduced ejection fraction, and is used after myocardial infarction to improve cardiovascular outcomes.

GNH India supplies Metoprololsuccinat Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Heumann Pharma Gmbh & Co. Generica Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metoprolol succinate acts on the cardiovascular system to control blood pressure and heart workload.

  • Hypertension: lowers systemic blood pressure and reduces cardiovascular risk.
  • Chronic stable angina: decreases myocardial oxygen demand, relieving chest pain.
  • Heart failure (reduced ejection fraction): improves survival and reduces hospitalisations.
  • Post‑myocardial infarction: lowers the risk of recurrent events and improves long‑term outcomes.

How It Works

  • Metoprolol succinate selectively antagonises β1‑adrenergic receptors in cardiac tissue, diminishing sympathetic stimulation. This leads to a reduction in heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and decreasing myocardial oxygen consumption.

Side Effects

Metoprolol succinate may cause a range of adverse reactions.

Common Side Effects

  • Fatigue: feeling unusually tired or weak.
  • Dizziness: light‑headedness, especially when standing.
  • Headache: mild to moderate intensity.
  • Bradycardia: slower than normal heart rate.
  • Cold extremities: reduced peripheral circulation.
  • Gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects

  • Severe bradycardia: markedly low heart rate requiring medical attention.
  • Heart block: impaired electrical conduction of the heart.
  • Hypotension: dangerously low blood pressure.
  • Bronchospasm: narrowing of airways, especially in patients with asthma.
  • Allergic reactions: rash, urticaria, or angio‑edema.
  • Depression: mood changes or depressive symptoms.

Precautions & Warnings

Before initiating therapy, consider the following precautions.

  • Dose adjustment in renal impairment: reduce dose as needed based on renal function.
  • Monitor heart rate and blood pressure: check regularly during titration.
  • Use with caution in asthma or COPD: may exacerbate bronchospasm.
  • Avoid abrupt discontinuation: taper to prevent rebound hypertension.
  • Store at room temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Metoprolol succinate can interact with several medicines.

Major Interactions (Avoid)

  • Non‑selective beta‑blockers: additive bradycardia.
  • Calcium channel blockers (verapamil, diltiazem): risk of severe AV block.
  • Clonidine: may cause rebound hypertension if stopped.
  • Anti‑arrhythmic agents (e.g., amiodarone): increased risk of bradycardia.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors/ARBs: may enhance hypotensive effect.
  • Diuretics: may cause excessive blood pressure drop.
  • Insulin or oral hypoglycemics: may mask hypoglycaemia symptoms.

Frequently Asked Questions

Metoprololsuccinat Heumann is a prescription beta‑blocker indicated for the management of hypertension, chronic stable angina, heart failure with reduced ejection fraction, and secondary prevention after myocardial infarction. It works by lowering heart rate and myocardial oxygen demand, helping to protect the cardiovascular system.

Metoprolol Succinate selectively blocks β1‑adrenergic receptors in the heart, reducing sympathetic stimulation. This decreases heart rate, contractility, and cardiac output, which lowers blood pressure and reduces the heart’s oxygen requirements, providing therapeutic benefit in several cardiac conditions.

The exact dose is individualized by the prescribing clinician based on the patient’s specific condition, response, and renal function. Dosage may start low and be titrated upward according to local prescribing guidelines and clinical judgement.

Safety in pregnancy and lactation has not been fully established. The drug is generally avoided unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative therapies with their healthcare provider.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol Succinate is a long‑acting, selective β1‑blocker offering once‑daily dosing and smoother plasma concentrations compared with short‑acting agents like metoprolol tartrate. Compared with non‑selective beta‑blockers, it carries a lower risk of bronchospasm in patients with respiratory disease.

Store at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children. Do not use if the tablet shows signs of damage or discoloration.

Metoprololsuccinat Heumann is taken orally, usually once daily with or without food. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed by a pharmacist.

Serious adverse events include severe bradycardia, symptomatic hypotension, heart block, bronchospasm, and allergic reactions such as rash or angio‑edema. Seek immediate medical attention if you experience fainting, chest pain, difficulty breathing, or swelling of the face or throat.

Contra‑indications include patients with second‑ or third‑degree AV block without a pacemaker, uncompensated heart failure, severe bradycardia, cardiogenic shock, and known hypersensitivity to metoprolol or any excipients. Caution is also advised in severe asthma or COPD.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metoprolol Succinate (Ph. Eur.)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT